Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment
Clinical trial NCT00002419 · COMPLETED
Trial details
- NCT number
- NCT00002419
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.